Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 2Warts 1Uterine Cervical Dysplasia 1Infections 1High Grade Anal Canal Intraepithelial Neoplasia 1Condylomata Acuminata 1Cancer Survivor 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cryotherapy 2Cholecalciferol 2Cantharidin 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1green tea extract polyphenone E 1VP-102 1Sugars 1Photochemotherapy 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Maltose 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Warts × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡